Jeannette Y. Wick, RPh, MBA, FASCP

Metformin and DPP-4 inhibitor dual therapy provides less durable glycemic control than the addition of sulfonylureas or TZD to metformin in diabetics.

Tight glucose control tempers insidious progress of diabetes. Nevertheless, lifestyle modifications and metformin monotherapy eventually fail to control blood glucose sufficiently in most patients.

Diabetes costs the United States more than $300 billion annually.

Cardiovascular disease (CVD) costs the United States $444 billion each year.

The leading cause of death worldwide is preventable.

Affordable Care Act provides reimbursements for diabetes self-management education and support programs for pharmacists with recognized credentials.

Diabetes costs the United States more than $300 billion annually, so concerted efforts are needed to manage this disease.

Diabetes has the dubious distinction of being the 7th leading cause of death and the leading cause of kidney failure, non-traumatic lower-limb amputations, and blindness in the United States.

The impact of zidovudine, nelfinavir, and lamivudine prophylaxis in treating neonatal HIV transmission.

Antepartum, intrapartum, and postpartum antiretroviral prophylaxis can drastically reduce the chance of HIV transmission.

Despite the fact that the risk of perinatal HIV transmission can be reduced to less than 1% with appropriate care, around 75% of HIV-positive children were infected perinatally in 2010.

The disease of kings" can be a royal pain.

Pharmacists can aggressively intervene to adjust medications when patients’ diabetes is uncontrolled.

Did you know that diabetes is a common problem in prisons?

Multifaceted interventions with multiple members of the diabetes patient care team found more effective.

Cancer’s long-term side effects on fertility should be discussed with parents of young cancer patients.

Around 28,000 influenza infections are severe enough to warrant intensive care unit admissions each year.

As the diabetic population continues to swell, diabetes care has shifted from being the purview of strictly endocrinologists to a focus for all health care providers.

Alzheimer's disease, a neurological disorder expected to more than triple in incidence by 2051, has some interesting similarities with infections like the flu.

Anti-malarial and immunomodulating agents chloroquine and hydroxychloroquine favorably impact lipoprotein metabolism.

Coughing is a simple brainstem-mediated reflex, but the urge to cough follows a complex pathway across higher-order brain regions.

All diabetic neuropathies increase risk of all-cause death and adversely affect quality of life.

Only a handful of medications carry an FDA indication for obesity.

Drug therapy must balance the potential to improve quality of life with the risk of adverse effects. In the context of ever-increasing treatment complexity, striking this balance is getting complicated.

Pharmacists can reduce inappropriate PPI use and help patients discontinue unnecessary PPIs through these interventions.

Patients often leave the hospital on different and more complicated drug therapies.

Some treatment guidelines recommend watchful waiting in low-risk children who develop ear infections and generally ignore or exclude complementary and alternative medicine use, even in countries that embrace these methods.

Can urate-lowering therapy for gout also reduce cardiovascular risk and mortality?

Traditional adherence aids, such as pillboxes and blister packaging, help patients organize their medications by day and time, while new technologies can also address medications not included in pillboxes, such as inhalers and insulin pens.

Patients frequently overuse proton pump inhibitors for unapproved indications in place of more expensive and powerful agents.